<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Rizzo, Toni</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Deharo, Jean-Claude</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Silent Atrial Fibrillation: When to Treat?</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2012</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2012-11-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">20-21</style></pages><abstract><style  face="normal" font="default" size="100%">Atrial fibrillation (AF) is the most common sustained cardiac rhythm disorder, affecting 3 million people in the United States and 35 million worldwide. Patients with AF have a substantial risk for mortality and morbidity from ischemic stroke, which occurs at 5 times the rate as in the general population. The risk of stroke in people with AF is about 5% per year and AF-related strokes tend to be more severe than strokes in patients without AF [Magnani JW et al. Circulation 2011]. This article discusses the diagnosis and treatment of silent AF.</style></abstract><number><style face="normal" font="default" size="100%">8</style></number><volume><style face="normal" font="default" size="100%">12</style></volume></record></records></xml>